Doctronic Raises $20M to Make Primary Care Instantly Accessible Through AI-Powered Medical Consultations

The U.S. healthcare system faces a critical access crisis: Americans wait an average of three weeks to see a primary care physician, while nearly one-third of adults lack consistent access to primary care entirely. This gap forces patients to turn to Google and WebMD for medical guidance, creating a dangerous disconnect between urgent health concerns and reliable clinical information. Doctronic addresses this access problem by delivering AI-powered medical consultations in minutes rather than weeks, combining free, anonymous symptom assessments with on-demand access to licensed physicians across all 50 states for $39 per video visit. The platform has already processed over 15 million medical conversations with more than 1 million unique users, handling 50,000 weekly visits through its collective intelligence architecture where multiple specialized AI agents engage in clinical reasoning under physician oversight. With recent peer-reviewed research showing 99.2% treatment alignment with board-certified clinicians, Doctronic operates as a complementary force for an overstretched healthcare system projected to face a shortage of 124,000 physicians by 2034.

AlleyWatch sat down with Doctronic Co-Founder and CEO Matt Pavelle to learn more about the business, the company’s unique micro-agentic consensus architecture, recent partnerships with payers and health systems, recent funding round that brings total funding raised to $25M, and much, much more…

Who were your investors and how much did you raise?We raised $20M in our Series A, led by Lightspeed Venture Partners. Union Square Ventures, who led our seed round in February, participated alongside several strategic investors including Tusk Ventures, Seven Stars, Mantis Ventures, and DVC. We had some incredible angels come in too like Fei-fei Li, Jay Desai, and Scott Belsky. We’re grateful to work with investors who understand both healthcare’s complexity and AI’s potential.

Tell us about the product or service that Doctronic offers.Doctronic is an AI doctor available 24/7. Anyone can have a free, anonymous consultation to explore symptoms, understand potential diagnoses, and get personalized health guidance. We are private, HIPAA-compliant, and don’t train on user data. Our AI uses a proprietary micro-agentic consensus architecture with thousands of custom doctor-written clinical guidelines. For patients needing immediate treatment, our licensed physicians are available across all 50 states 24/7 for a video visit that costs only $39.

What inspired the start of Doctronic?Americans wait three weeks on average to see a primary care doctor. When people feel sick, they turn to WebMD or Google and end up overwhelmed with data lacking any real clinical connection to their needs. We built Doctronic to give everyone immediate access to accurate medical guidance and to help patients have better, more informed conversations with their doctors.

How is Doctronic different?We’re the only medical AI anchored in privacy, accessibility, and clinical validation. Everything is anonymous by default, HIPAA compliant, and we never train on user data. Our peer-reviewed research demonstrates board-certified clinicians agree with our AI’s treatment plans in over 99% of cases—tested in real clinical practice, not simulations. We are also the only AI first telehealth practice with real human doctors available for video calls to handle patient needs 24/7. We can also automatically import patient health records, creating the best “medical memory” in healthcare while maintaining complete privacy.

What market does Doctronic target and how big is it?Primary care is our focus. The U.S. faces a projected 120,000 physician deficit by 2030, and consumers already choose AI for health guidance. We’re building the digital front door for healthcare—where patients start and end their journey. The market opportunity is massive (hundreds of billions of dollars) and the need is urgent.

What’s your business model?We have multiple revenue streams: direct-to-consumer telehealth visits, B2B2C partnerships with employers and health plans, integrations with health systems who embed our AI on their websites, and prescription services. Our AI-driven efficiency enables profitable unit economics at low cost per visit, letting us offer capabilities free that competitors must charge for.

How are you preparing for a potential economic slowdown?We operate with disciplined capital efficiency while maintaining growth. Our AI-first model scales without proportionally scaling costs. Economic uncertainty actually increases demand for our solution as we reduce healthcare costs for patients, employers, and payers while improving access and outcomes.

What was the funding process like?

Lightspeed preempted our Series A just months after closing our seed with USV. Strong execution creates momentum. We’re processing tens of millions of consults with millions of users, and tens of thousands of people use Doctronic daily with an NPS in the high 60s. When you’re solving a real problem at scale, investors move quickly.

What are the biggest challenges that you faced while raising capital?Healthcare AI requires proving clinical accuracy, regulatory clarity, and sustainable business models. We addressed this head-on with peer-reviewed research demonstrating 99.2% treatment plan alignment with clinicians in real-world practice, a clear regulatory strategy including applications to state sandboxes, and proven unit economics. These challenges quickly became advantages as they forced us to build with rigor from day one, and investors responded accordingly once they were in place.

What are the biggest challenges that you faced while raising capital?Healthcare AI requires proving clinical accuracy, regulatory clarity, and sustainable business models. We addressed this head-on with peer-reviewed research demonstrating 99.2% treatment plan alignment with clinicians in real-world practice, a clear regulatory strategy including applications to state sandboxes, and proven unit economics. These challenges quickly became advantages as they forced us to build with rigor from day one, and investors responded accordingly once they were in place.

What factors about your business led your investors to write the check?Clinical validation at scale, defensible network effects, and multiple revenue streams. Our integrated EHR creates switching costs while enabling massive personalization. We control the patient relationship, care coordination layer, and data—not just one piece of the stack. We’re also demonstrating efficient growth with strong unit economics, which matters in any market environment.

What are the milestones you plan to achieve in the next six months?We’re scaling in every way. We’re expanding our provider network to reduce wait times, and deepening B2B2C partnerships with major payers and health systems. We’ll continue publishing peer-reviewed research demonstrating clinical accuracy. Our goal is to raise the floor of healthcare quality for everyone. I think we’ll hit 30 million AI consults and 50k human doctor visits pretty easily.

What advice can you offer companies in New York that do not have a fresh injection of capital in the bank?Focus relentlessly on product-market fit. Capital is available for companies solving real problems efficiently. In regulated industries like healthcare, validation and compliance aren’t obstacles, they’re moats. Build something people need, prove it works, manage your burn, and the capital will follow.

Where do you see the company going now over the near term?We’re building toward a future where the majority of primary care is AI-delivered, accessible to anyone, anywhere, anytime. Near term means proving this model works across diverse populations, strengthening our clinical evidence, and expanding partnerships that give millions of Americans better healthcare access. We’re not debating whether AI becomes the front door for healthcare, we’re building it.

What’s your favorite fall destination in and around the city?Hands down Central Park. New York is the best city in the world and fall in New York is the best season. A walk in the park is perfect for clearing your head.